Patient perspectives on Parkinson’s disease therapy in Japan and the United States: results of two patient surveys
Open Access
- 1 July 2012
- journal article
- Published by Taylor & Francis in Patient Related Outcome Measures
- Vol. 3, 31-8
Abstract
Peer reviewed article authored by (Hattori N, Fujimoto K, Kondo T, Murata M, Stacy M). Read article or submit your manuscript for publishing.Keywords
This publication has 17 references indexed in Scilit:
- The Impact in Japan of Regulatory Action on Prescribing of Dopamine Receptor AgonistsDrug Safety, 2011
- Levodopa in the treatment of Parkinson’s disease: an old drug still going strongClinical Interventions in Aging, 2010
- A reassessment of risks and benefits of dopamine agonists in Parkinson's diseaseThe Lancet Neurology, 2009
- Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and TreatmentsEuropean Neurology, 2008
- Patients' views on chronic illness and its care in general practice.2005
- Low-dose Levodopa Therapy in Japanese Patients with Parkinson's Disease: A Retrospective StudyInternal Medicine, 2005
- Perceived Stigma as a Predictor of Treatment Discontinuation in Young and Older Outpatients With DepressionAmerican Journal of Psychiatry, 2001
- Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson DiseaseArchives of Neurology, 1999
- Effective physician-patient communication and health outcomes: a review.1995
- ParkinsonismNeurology, 1967